Macular Degeneration Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are able to understand the study and agree to take part in it
- Healthy people with no eye or other conditions
- People who have been diagnosed with age-related macular degeneration (AMD), diabetic retinopathy, central serous chorioretinopathy (a condition affecting the back of the eye), and/or glaucoma or suspected glaucoma
- For a specific part of the study only: people who have been diagnosed with Alzheimer's disease or mild cognitive impairment (early-stage memory and thinking changes)
Who may not be able to join:
- People taking certain long-term medications (such as corticosteroids, hydroxychloroquine, chloroquine, thioridazine, or canthaxanthine), or people who have conditions such as stroke that affect vision or the thickness of the retina, apart from glaucoma
- People who have a squint (eyes that don't align), uncontrolled eye movements (nystagmus), or any condition that makes it difficult to hold a steady gaze
- People who have cloudiness or other issues inside the eye that block a clear view of the back of the eye, or any non-glaucoma-related eye abnormality inside the eye
- People who have had an eye injury or eye surgery, other than uncomplicated glaucoma treatment or cataract removal that took place at least 3 months before joining the study
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Joel S Schumann, MD, Wills Eye Hospital
Phone: 215-928-3197
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Number of Participants who Show Evidence of Glaucoma Progression
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.